Clause,Predicted Label,Confidence
"This Distribution Agreement is entered into by Meditek Pharma and Genomix Inc., effective April 15, 2025.",exclusivity,0.717
Meditek agrees to share 5% of net revenue from licensed products with Genomix for every quarter.,revenue/profit sharing,0.995
"Post-termination, Genomix shall assist in the transfer of licensing rights to any successor.",post-termination services,0.995
The Agreement shall remain in effect for 2 years and may be terminated for convenience by either party with 30 days' written notice.,post-termination services,0.92
Governing law: State of New York.,governing law,0.997
